Resolution of Fenfluramine-associated pulmonary arterial hypertension in Lennox-Gastaut syndrome: A case report and literature review

Fenfluramine is a medication originally approved for weight loss before being withdrawn for an association with the development of pulmonary arterial hypertension (PAH) and cardiac valvulopathy. Interest in fenfluramine at lower doses has re-emerged for treatment of drug-resistant epilepsy (DRE). He...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Rebecca Strafella, Richard Wang, Marissa Petchpradub, Ariel Sacknovitz, Patricia E. McGoldrick, Steven M. Wolf
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2024-01-01
Serie:	Epilepsy & Behavior Reports
Soggetti:	Drug-resistant epilepsy LGS Lennox-Gastaut Syndrome Fintepla
Accesso online:	http://www.sciencedirect.com/science/article/pii/S258998642400087X
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!